节点文献

CEA和CAl25联检在乳腺癌化疗中的价值分析

The CEA and CAl25 joint inspection in breast cancer chemotherapy the values of Analysis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 周养谋孙延亮陆长庚唐伟建

【Author】 ZHOU Yangmou SUN Yanliang LU Changgeng TANG Weijian The first hospital,Hunan Province,Huaihua 418000,China

【机构】 怀化市一医院

【摘要】 目的探讨肿瘤标志物在乳腺癌化疗前后的监测价值。方法采用化学发光法测定38例乳腺癌患者化疗前后的血清CEA和CAl25水平。结果血清CEA和CAl25的水平变化与乳腺癌患者化疗的临床疗效关系密切,疗效越好,其水平下降越明显,前后差异有统计学意义(P<0.05)。结论 CEA和CAl25可较好地监测乳腺癌化疗疗效,两者联检将提高乳腺癌化疗的监测效果。

【Abstract】 objective to study the tumor markers in breast cancer chemotherapy before and after the monitoring value.Methods using chemiluminescence determination of 38 cases of breast cancer chemotherapy before and after the serum CEA and CAl25 level.Results the level of serum CEA and CAl25 changes with the clinical curative effect of breast cancer chemotherapy close relations,the better the results,the level of decline,the more obvious difference was statistically significant before and after(P<0.05);Conclusion the CEA and CAl25 can better monitoring breast cancer chemotherapy curative effect,both joint inspection will improve breast cancer chemotherapy monitoring results.

【关键词】 乳腺癌化疗CEACAl25
【Key words】 breast cancerChemotherapyThe CEACAl25
  • 【文献出处】 中外医疗 ,China Foreign Medical Treatment , 编辑部邮箱 ,2011年15期
  • 【分类号】R737.9
  • 【下载频次】65
节点文献中: 

本文链接的文献网络图示:

本文的引文网络